TCL Archive As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data. October 22, 2004
TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive CCOP Applications Total 162; Three Committees, Headed By Ahmann, Loeb, Spur Will Review Them November 19, 1982